AnalystBro Research
Research
Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.
2 articles.
Bangladesh All Bangladesh research →
Company · DSE:UNITEDFIN · Financial Institutions · Analysis · 31 Oct 2026
United Finance in 2025: 5.95% classified loans, a 9.24% cost of fund, 5.92% ROE and 94% of EPS paid out
A lease and term lender with BDT 20.7bn of loans, an 18.45% capital ratio and an unmodified audit opinion. Classified loans and the cost of fund were the highest of the 2021-2025 series in 2025; H1 2026 profit rose to BDT 50.3m from BDT 32.4m.
Company · DSE:TECHNODRUG · Pharmaceuticals & healthcare · Analysis · 31 Oct 2026
Techno Drugs: FY2026 EPS of BDT 1.51 against 1.76, and BDT 129.8m of overdue loan interest disclosed in October 2026
The contraceptive supplier to the government reported FY2026 EPS of BDT 1.51 against 1.76, finance expenses at 11.2% of nine-month revenue, and told DSE in October 2026 that BDT 12.98 crore of loan interest was overdue; the board kept a 10% cash dividend for non-sponsor holders.